Fri, March 15, 2024

Esther Rajavelu Maintained (APLT) at Strong Buy with Increased Target to $13 on, Mar 15th, 2024

Esther Rajavelu of UBS, Maintained "Applied Therapeutics, Inc." (APLT) at Strong Buy with Increased Target from $12 to $13 on, Mar 15th, 2024.

Esther has made no other calls on APLT in the last 4 months.



There are 2 other peers that have a rating on APLT. Out of the 2 peers that are also analyzing APLT, 0 agree with Esther's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Esther


  • Joseph Schwartz of "Leerink Partners" Initiated at Buy and Held Target at $12 on, Thursday, February 22nd, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $7 on, Friday, February 16th, 2024